Target Name: MRPL48
NCBI ID: G51642
Review Report on MRPL48 Target / Biomarker Content of Review Report on MRPL48 Target / Biomarker
MRPL48
Other Name(s): mitochondrial ribosomal protein L48 | L48mt | CGI-118 | mitochondrial large ribosomal subunit protein mL48 | MRPL48 variant 1 | RM48_HUMAN | HSPC290 | 39S ribosomal protein L48, mitochondrial | Mitochondrial ribosomal protein L48, transcript variant 1 | FLJ99260 | L48MT | MRP-L48 | MGC13323 | FLJ17047 | Mitochondrial large ribosomal subunit protein mL48 | 39S ribosomal protein L48, mitochondrial (isoform 1)

Role of Mitochondrial Ribosomal Protein L48 in Cellular Processes

Mitochondrial Ribosomal Protein L48 (MRPL48) is a protein that plays a crucial role in the structure and function of mitochondria, which are organelles found in the cells of most eukaryotes. Mitochondria are responsible for generating the energy that cells need to perform various physiological functions, and they are also involved in the production of the molecules that make up the cell nucleus.

One of the key functions of MRPL48 is its role in the structure of the mitochondrial matrix, which is the space between the mitochondria and the cytoplasm. The matrix is composed of a series of protein fibers that are organized in a specific pattern to create a three-dimensional structure that is essential for the proper functioning of the mitochondria.

MRPL48 is also involved in the regulation of mitochondrial dynamics, which refers to the movement of mitochondria within the cytoplasm. This is important for various cellular processes, including the transport of oxygen and nutrients to the cells' various organelles and the removal of waste products.

In addition to its role in the structure and function of the mitochondria, MRPL48 has also been shown to play a potential drug target or biomarker in several studies.

One potential drug target for MRPL48 is its role in the regulation of mitochondrial dynamics. Several studies have shown that modulating the activity of MRPL48 can have a significant impact on the dynamics of mitochondria, including their movement and their ability to access certain cellular organelles. This suggests that MRPL48 could be a useful target for drugs that are designed to improve mitochondrial function and potentially treat a variety of conditions.

Another potential drug target for MRPL48 is its role in the regulation of cellular processes that are dependent on the activity of mitochondria. Several studies have shown that MRPL48 is involved in the production of various cellular compounds, including proteins, lipids, and nucleic acids. This suggests that modulating the activity of MRPL48 could have a significant impact on cellular processes and potentially be a useful target for drugs that are designed to treat a variety of conditions.

In addition to its potential drug targets, MRPL48 has also been shown to be a potential biomarker for a variety of diseases. Several studies have shown that levels of MRPL48 are elevated in the cells of individuals with a variety of diseases, including cancer, neurodegenerative diseases, and metabolic disorders. This suggests that MRPL48 could be a useful biomarker for these diseases and potentially be used for diagnostic purposes.

Overall, MRPL48 is a protein that plays a crucial role in the structure and function of mitochondria and has been shown to have potential drug target and biomarker properties. Further research is needed to fully understand the role of MRPL48 in cellular processes and to determine its potential as a drug target or biomarker.

Protein Name: Mitochondrial Ribosomal Protein L48

The "MRPL48 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MRPL48 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MRPL49 | MRPL50 | MRPL51 | MRPL52 | MRPL53 | MRPL54 | MRPL55 | MRPL57 | MRPL57P1 | MRPL57P8 | MRPL58 | MRPL9 | MRPL9P1 | MRPS10 | MRPS10P2 | MRPS11 | MRPS12 | MRPS14 | MRPS15 | MRPS16 | MRPS17 | MRPS18A | MRPS18B | MRPS18C | MRPS18CP2 | MRPS18CP4 | MRPS18CP7 | MRPS2 | MRPS21 | MRPS22 | MRPS23 | MRPS24 | MRPS25 | MRPS26 | MRPS27 | MRPS28 | MRPS30 | MRPS30-DT | MRPS31 | MRPS31P2 | MRPS31P4 | MRPS31P5 | MRPS33 | MRPS33P4 | MRPS34 | MRPS35 | MRPS35-DT | MRPS36 | MRPS36P4 | MRPS5 | MRPS6 | MRPS7 | MRPS9 | MRRF | MRS2 | MRS2P2 | MRTFA | MRTFB | MRTO4 | MS4A1 | MS4A10 | MS4A12 | MS4A13 | MS4A14 | MS4A15 | MS4A18 | MS4A2 | MS4A3 | MS4A4A | MS4A4E | MS4A5 | MS4A6A | MS4A6E | MS4A7 | MS4A8 | MSANTD1 | MSANTD2 | MSANTD3 | MSANTD4 | MSC | MSC-AS1 | MSGN1 | MSH2 | MSH3 | MSH4 | MSH5 | MSH5-SAPCD1 | MSH6 | MSI1 | MSI2 | MSL1 | MSL2 | MSL3 | MSL3P1 | MSLN | MSLNL | MSMB | MSMO1 | MSMP | MSN